Aptorum Group Limited

APM

Biotechnology · Healthcare

Price

$8.99

-0.55 (-5.77%)

Market Cap

$5.7M

Exchange

NASDAQ

Winston Score

–

No score yet — Winston is napping.

We couldn’t gather enough financial data to score this stock reliably.

Share count rising — dilution

+109.9% over 4y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 350K (2021) → 735K (2025)

Aptorum Group Limited is a small biotechnology company based in Hong Kong that focuses on developing new medicines and medical technologies. The company works on treatments for infectious diseases, neurological conditions, and other serious illnesses. It also has a branch that provides medical services through clinics in Hong Kong.

Aptorum makes very little revenue today because most of its drug candidates are still in early research and clinical testing stages. The company operates primarily in Hong Kong and has ties to research institutions in the United States and Europe. Its market cap is extremely small, which means it has limited resources to fund the expensive process of getting drugs approved. The biggest risk Aptorum faces is running out of cash before any of its drug candidates successfully complete clinical trials and reach the market, which is a common challenge for early-stage biotech companies.

Winston Score History

Growth Profile

For growth stock investors

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

YoY Growth Rate

Revenue data limited

EPS Growth

+55.2% YoY

YoY Growth Rate

EPS growth accelerating

R&D Spend

$352,879/ year

↓ Declining (-82% vs prior year)

R&D spend declining — could signal cost-cutting or efficiency

Insider Activity

15.6%ownership

Insiders own a meaningful stake in the company

Cash Position

Cash flow positive

$19M cash & investments

Quarterly Free Cash Flow

↑ Burn rate improving

Company generates more cash than it spends — no dilution risk from fundraising

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin

N/A

Data not available

Operating Margin

N/A

Data not available

ROCE

-5.3%

Weak — -5.3% return on capital

Negative ROIC means the business is losing money on every dollar invested in it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY

N/A

Data not available

EPS YoY

N/A

Data not available

EPS Consistency

0/8 quarters

Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion

N/A

Data not available

FCF Margin

-124.0%

Burning cash (-124.0%)

Free cash flow is negative. They are burning cash, not generating it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity

0.15

Conservative — low debt load (0.15)

Interest Cover

N/A

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)

N/M

Negative earnings — P/E not meaningful

P/E vs Forward

N/A

not available

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.

🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.

Start free trial